Director Gold Alexander M sold shares of Mineralys Therapeutics ($MLYS) on the open market five times over the past year for a total of $1.58 million. His latest sale was on November 13, 2025. These transactions rank 3,954th out of 11,678 insiders in the database, trailing the average sale value of $8.59 million across 6.37 trades. Gold Alexander M recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | A | Stock Option | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 9999.99% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | A | Common Stock | 6200 | $0.00 | 6,200.0000 | 79,139,956 | 9999.99% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | S | Common Stock | 10000 | $42.43 | 5,000.0000 | 79,139,956 | 66.67% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | S | Common Stock | 5000 | $47.08 | 0.0000 | 79,139,956 | 100.00% | 0.01% |
| Nov. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Common Stock | 6933 | $10.20 | 6,933.0000 | 79,139,956 | 9999.99% | 0.01% |
| Nov. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | S | Common Stock | 5000 | $46.50 | 1,933.0000 | 79,139,956 | 72.12% | 0.01% |
| Nov. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | S | Common Stock | 1933 | $47.28 | 0.0000 | 79,139,956 | 100.00% | 0.00% |
| Nov. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Common Stock | 10000 | $12.69 | 12,742.0000 | 79,139,956 | 364.70% | 0.01% |
| Nov. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | S | Common Stock | 12742 | $46.50 | 0.0000 | 79,139,956 | 100.00% | 0.02% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Stock Option | 15000 | $0.00 | 17,900.0000 | 79,139,956 | 45.59% | 0.02% |
| Nov. 12, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Stock Option | 6933 | $0.00 | 10,967.0000 | 79,139,956 | 38.73% | 0.01% |
| Nov. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Stock Option | 2742 | $0.00 | 8,225.0000 | 79,139,956 | 25.00% | 0.00% |
| Nov. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Stock Option | 10000 | $0.00 | 34,000.0000 | 79,139,956 | 22.73% | 0.01% |
| Nov. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Common Stock | 2742 | $10.20 | 2,742.0000 | 79,139,956 | 9999.99% | 0.00% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | M | Common Stock | 15000 | $10.20 | 15,000.0000 | 79,139,956 | 9999.99% | 0.02% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | A | Stock Option | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 9999.99% | 0.07% |
| June 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Gold Alexander M | Director | A | Stock Option | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |